Maxcyte (MXCT) Change in Inventory (2020 - 2026)

Maxcyte (MXCT) has reported Change in Inventory for 7 consecutive years, with $472000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Inventory rose 311.66% year-over-year to $472000.0 in Q2 2026; TTM through Jun 2026 was $1.0 million, a 180.36% increase from a year earlier, with the FY2025 full-year figure at -$575000.0, up 57.78% from the prior year.
• Change in Inventory was $472000.0 for Q2 2026 at Maxcyte, up from $380000.0 in the prior quarter.
• Over five years, Change in Inventory peaked at $1.7 million in Q1 2023 and troughed at -$664000.0 in Q2 2024.
• A 5-year average of $385666.7 and a median of $310600.0 in 2022 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory tumbled 218.16% in 2024 and surged 5450.0% in 2025, its largest moves.
• Over 5 years, Change in Inventory stood at $612300.0 in 2022, then decreased by 27.16% to $446000.0 in 2023, then plunged by 218.16% to -$527000.0 in 2024, then surged by 113.66% to $72000.0 in 2025, then jumped by 555.56% to $472000.0 in 2026.
• The last three Change in Inventory figures came in at $472000.0 (Q2 2026), $380000.0 (Q1 2026), and $72000.0 (Q4 2025), per Business Quant data.